Invesaro

Stocks PRPO Financial statements

Financial statements

Precipio, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Precipio, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2.12.94.98.1815.917.720.329.541.853.5
Cost of revenue0.971.432.642.914.946.466.99.181113.3
Gross profit0.750.290.230.221.152.392.516.027.5610.7
Research and development00.51.11.21.21.31.71.71.31.6
Selling, general and administrative2.476.499.459.6210.3
Operating expenses2.4715.814.111.210.31215.313.611.811.9
Operating income-1.71-15.5-13.9-11-9.15-9.61-12.8-7.62-4.22-1.2
Other non-operating income0-0.070.84
Pre-tax income-2.23-20.7-16-13.3-10.6-8.52-12.2-5.85-4.29-0.36
Income tax00.35-0.28-0.07000000
Income from continuing operations-2.23-20.7-15.7-13.2-10.6-8.52
Net income to minority interests0.030.010.03
Net income-2.23-20.7-15.7-13.2-14-8.53-12.2-5.85-4.29-0.36
EBITDA-1.6-14.8-12.6-9.88-8.05-8.48-11.6-6.4-3.020.04
EPS, basic-2,818.00-2,137.00-274.61-46.30-16.89-7.95-10.73-4.51-2.93-0.23
EPS, diluted-2,818.00-2,137.00-274.61-46.30-16.89-7.95-10.73-4.51-2.93-0.23
Shares, basic (weighted)00.020.070.290.831.061.141.31.471.61
Shares, diluted (weighted)00.020.070.290.831.061.141.31.471.61

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.050.420.380.852.6611.73.451.51.392.65
Receivables0.390.730.690.570.870.71.041.30.81.98
Inventory0.10.160.20.180.350.560.710.380.720.94
Other current assets0.010.430.530.270.320.550.520.50.540.47
Total current assets0.551.741.791.884.213.55.713.683.456.04
Property, plant and equipment0.280.350.50.430.280.840.880.740.720.73
Lease right-of-use assets0.520.310.860.760.610.42.57
Goodwill4.69
Intangible assets020.519.316.715.714.713.812.811.910.9
Other non-current assets0.010.020.030.030.060.180.130.080.050.07
Total assets0.8427.321.619.520.730.421.518.11721.3
Accounts payable1.085.15.171.941.691.862.040.620.621.13
Accrued liabilities0.71.251.941.642.041.921.581.822.81.69
Deferred revenue0.090.070.050.040.010.020.120.110.230.28
Short-term debt0.40.590.260.320.650.030.260.240.30.03
Total current liabilities3.011013.84.334.664.214.363.144.273.75
Long-term debt4.132.830.250.20.360.160.130.110.080.05
Lease liabilities0.320.090.70.570.410.212.21
Other non-current liabilities00.070.05
Total liabilities7.314.215.56.316.555.845.143.674.96.76
Total debt4.523.420.520.541.030.190.40.350.380.08
Paid-in capital4.3844.553.874.185.5104109113115117
Retained earnings-10.8-31.5-47.7-60.9-71.6-80.1-92.3-98.2-102-103
Other comprehensive income0
Shareholders' equity-6.46136.1213.214.124.616.314.4
Minority interests0.030.040.07
Total equity-6.46136.1213.214.224.616.414.412.114.6
Total liabilities and equity0.8427.321.619.520.730.421.518.11721.3
Shares outstanding00.030.120.40.881.141.141.421.491.78

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-2.23-20.7-15.7-13.2-10.6-8.52-12.2-5.85-4.29-0.36
Depreciation and amortization0.110.741.271.121.091.131.221.231.21.25
Stock-based compensation0.010.050.530.670.71.883.81.561.491.21
Change in receivables-0.31-0.5-0.54-0.85-1.640.33-0.75-0.480.44-1.36
Change in inventory-0.02-0.05-0.040.01-0.17-0.21-0.140.32-0.34-0.21
Change in payables0.340.50.31-1.88-0.240.110.17-0.17-0.010.51
Cash from operations-0.96-6.69-6.75-9.14-7.43-6.58-7.72-3.560.440.69
Capital expenditures-0.02-0.14-0.1-0.06-0.15-0.68-0.28-0.13-0.22-0.33
Cash from investing1.01-0.04-0.1-0.06-0.1-0.68-0.28-0.13-0.22-0.33
Debt issued0.530.320.30.790.25
Stock issued0.482.016.638.9316.20.132.250.080.12
Cash from financing0.787.16.819.669.3416.3-0.231.74-0.330.9
Exchange rate effect0
Net change in cash-0.180.37-0.040.471.819.01-8.22-1.94-0.111.26
Free cash flow-0.98-6.83-6.85-9.2-7.59-7.26-8-3.690.220.36
Interest paid0.130.110.040.040.020.030.050.040.090.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $23.65 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin19.7%Gross profit / revenue.
Operating margin-2.5%Operating income / revenue.
EBITDA margin-0.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-2.0%Pre-tax income / revenue.
Net margin-2.0%Net income / revenue.
FCF margin1.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin1.8%Cash from operations / revenue.
Return on assets (ROA)-5.7%Net income / average total assets.
Stock-based pay / revenue3.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.5%Capital expenditures / revenue.
D&A / revenue1.9%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y28.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y38.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y27.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y41.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y62.2%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y56.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y56.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y66.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y25.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-0.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y0.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y9.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y12.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y14.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.77xCurrent assets / current liabilities.
Quick ratio1.45x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.83x(Cash + short-term investments) / current liabilities.
Debt / assets1.5%Total debt / total assets.
Liabilities / assets30.8%Total liabilities / total assets.
Net debt-$2.8MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$2.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets49.0%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover2.85xRevenue / average total assets.
Fixed asset turnover56.5xRevenue / average property, plant and equipment.
Inventory turnover19.6xCost of revenue / average inventory.
Days inventory19 days365 x average inventory / cost of revenue.
Receivables turnover26.7xRevenue / average receivables.
Days sales outstanding14 days365 x average receivables / revenue.
Days payables23 days365 x average accounts payable / cost of revenue.
Cash conversion cycle9 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow28.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.68Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$34.04Revenue / diluted weighted shares.
FCF per share$0.44Free cash flow / diluted weighted shares.
Operating cash flow per share$0.62Cash from operations / diluted weighted shares.
Cash per share$1.72(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$42.3MShare price x shares outstanding.
Enterprise value$39.6MMarket cap + total debt - cash - short-term investments.
P/S0.70xMarket cap / revenue.
P/FCF53.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF38.5xMarket cap / cash from operations, when positive.
EV/Sales0.65xEnterprise value / revenue.
EV/FCF50.2xEnterprise value / free cash flow, when both are positive.
FCF yield1.9%Free cash flow / market cap.
Earnings yield-2.9%Net income / market cap (the inverse of P/E).
What was Precipio, Inc.'s revenue in fiscal 2025?

Precipio, Inc. reported revenue of $53.5M for fiscal 2025, 28% higher than the year before.

Was Precipio, Inc. profitable in fiscal 2025?

No. It reported a net loss of $363.0K.

How much free cash flow did Precipio, Inc. generate in fiscal 2025?

Cash from operations of $685.0K minus capital expenditures of $326.0K left free cash flow of $359.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Precipio, Inc.